Korean Journal of Clinical Laboratory Science (대한임상검사과학회지)

Korean Society for Clinical Laboratory Science (대한임상검사과학회)
권호 표지
DOI QR코드

DOI QR Code

Histological Examination of Engineered Mesenchymal Stem Cells Improve Bladder Function in Rat

랫드에서 방광기능 향상의 엔지니어링 중간엽 줄기세포의 조직학적 소견

  • Cho, Eun Kyung (Department of Biomedical Laboratory Science, Kyungwoon University) ;
  • Jeon, Seung Hwan (Department of Urology, College of Medicine, The Catholic University of Korea)
  • 조은경 (경운대학교 임상병리학과) ;
  • 전승환 (가톨릭대학교 성의교정 비뇨의학과)
  • Received : 2020.05.20
  • Accepted : 2020.06.09
  • Published : 2020.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

This study was undertaken to examine the effects and to investigate the relevant mechanisms of overexpressing stromal cell-derived factor-1 (SDF-1) produced by engineered mesenchymal stem cells, in a neurogenic bladder (NB) rat model. Sprague-Dawley (SD) rats (N=48) were randomly divided into 4 groups comprising 12 rats each: control group, Injury group, Injury+imMSC group, and Injury+SDF-1 eMSC group. Rats in the Injury+imMSC group were treated with imMSCs, whereas the Injury+SDF-1 eMSC group were administered SDF-1 eMSCs. After 4-weeks therapy, the bladder and pelvic nerve (PN) tissues were examined by subjecting to Masson's trichrome staining and immunofluorescence. Administration of SDF-1 eMSC resulted in improved smooth muscle content in the bladder tissue, significantly increased β-III tubulin expression of the PN, and enhanced SDF-1 expression (P<0.05). The bladder wall repair can be attributed to the overexpression of SDF-1 by SDF-1 eMSCs. Significantly increased SDF-1 expression was obtained in the Injury+SDF-1 eMSC group (P<0.05). The crushed PN also showed significant recovery in the Injury+SDF-1 eMSC group (P<0.05). In conclusion, our results indicate that SDF-1 eMSCs express more SDF-1 in vivo, thereby facilitating the repair of injured nerve and recovery of NB in rats.

이 연구의 목표는 엔지니어링 중간엽 줄기세포에 의해 발현된 SDF-1의 효과를 규명하고 신경인성방광 랫 모델에서 관련 메커니즘을 조사하는 것이다. Sprague-Dawley 랫(N=48)을 대조군, 신경인성방광군, 신경인성방광군+imMSC군 및 신경 인성방광군+SDF-1 eMSC 군으로 무작위 선정하였다. 신경인성방광 랫 모델은 양측 골반 신경 손상으로 유도하였으며 골수 유래 중간엽 줄기세포를 immortalized한 MSC (empty vector)와 upregulated SDF-1한 MSC ( immortalized+SDF-1 치료유전차 발현)로 엔지니어링 하였다. 엔지니어링 중간엽줄기세포를 양측 골반 신경 손상부위와 방광에 주사하여 생착시켰다. 주사 4주 후 치료 효과를 양측골반신경 및 방광 조직을 마손 삼색 염색 및 면역 염색으로 분석하였다. 신경인성방광군+SDF-1 eMSC 군에서 방광 평활근이 유의하게 증가하였다(P<0.05). 신경마커 베타-III 튜불린 및 SDF-1 발현 또한 유의하게 증가하였으며(P<0.05), 이를 통해 손상된 신경을 복구하고, 신경인성 방광 랫 모델의 방광조직을 회복시켰다.

Keywords

References

  1. Emmanuel A. Neurogenic bowel dysfunction. F1000Res. 2019;8: F1000 Faculty Rev-1800. https://doi.org/10.12688/f1000research.20529.1
  2. Ismail S, Karsenty G, Chartier-Kastler E, Cussenot O, Comperat E, Roupret M, et al. Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: a systematic review. Neurourol Urodyn. 2018;37:1386-1395. https://doi.org/10.1002/nau.23457
  3. Panicker JN, Fowler CJ, Kessler TM. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol. 2015;14:720-732. https://doi.org/10.1016/S1474-4422(15)00070-8
  4. Welk B. Quality of life in neurourology patients. Eur Urol Focus. 2019;6:531-533. https://doi.org/10.1016/j.euf.2019.09.001
  5. Svihra J, Krhut J, Zachoval R, Svihrova V, Luptak J. Impact of clean intermittent catheterization on quality adjusted life years (QALYs) in spinal cord injury patients with neurogenic urinary incontinence. Neurourol Urodyn. 2018;37:250-256. https://doi.org/10.1002/nau.23283
  6. Romano B, Elangovan S, Erreni M, Sala E, Petti L, Kunderfranco P, et al. TNF-stimulated gene-6 is a key regulator in switching stemness and biological properties of mesenchymal stem cells. Stem Cells. 2019;37:973-987. https://doi.org/10.1002/stem.3010
  7. Zhu GQ, Jeon SH, Lee KW, Cho HJ, Ha US, Hong SH, et al. Engineered Stem Cells Improve Neurogenic Bladder by Overexpressing SDF-1 in a Pelvic Nerve Injury Rat Model. Cell transplantation. 2020;29:. https://doi.org/10.1177/0963689720902466
  8. Park HJ, Jeong H, Park YH, Yim HW, Ha US, Hong SH, et al. Adipose tissue-derived stem cell therapy for cavernous nerve injury- induced erectile dysfunction in the rat model: a systematic review and meta-analysis using methodological quality assessment. Int J Stem Cells. 2019;12:206-217. https://doi.org/10.15283/ijsc18122
  9. Rajabi S, Jalili-Firoozinezhad S, Ashtiani MK, Le Carrou G, Tajbakhsh S, Baharvand H. Effect of chemical immobilization of SDF-1alpha into muscle-derived scaffolds on angiogenesis and muscle progenitor recruitment. J Tissue Eng Regen Med. 2018; 12:e438-e450. https://doi.org/10.1002/term.2479
  10. Lavelle RS, Coskun B, Bacsu CD, Gliga LA, Christie AL, Lemack GE. Quality of life after suprapubic catheter placement in patients with neurogenic bladder conditions. Neurourol Urodyn. 2016;35:831-835. https://doi.org/10.1002/nau.22812
  11. Cameron AP, Rodriguez GM, Gursky A, He C, Clemens JQ, Stoffel JT. The severity of bowel dysfunction in patients with neurogenic bladder. J Urol. 2015;194:1336-1341. https://doi.org/10.1016/j.juro.2015.04.100
  12. Schöps TF, Schneider MP, Steffen F, Ineichen BV, Mehnert U, Kessler TM. Neurogenic lower urinary tract dysfunction (NLUTD) in patients with spinal cord injury: long-term urodynamic findings. BJU Int. 2015;115:33-38. https://doi.org/10.1111/bju.13085
  13. Barinov A, Luo L, Gasse P, Meas-Yedid V, Donnadieu E, Arenzana-Seisdedos F, et al. Essential role of immobilized chemokine CXCL12 in the regulation of the humoral immune response. Pro Natl Acad Sci U S A. 2017;114:2319-2324. https://doi.org/10.1073/pnas.1611958114
  14. Carbajal KS, Schaumburg C, Strieter R, Kane J, Lane TE. Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. Pro Natl Acad Sci U S A. 2010;107:11068-11073. https://doi.org/10.1073/pnas.1006375107